24.96
-0.77 (-2.97%)
| Previous Close | 25.72 |
| Open | 25.76 |
| Volume | 1,006,460 |
| Avg. Volume (3M) | 2,760,139 |
| Market Cap | 2,298,909,440 |
| Price / Earnings (TTM) | 12.23 |
| Price / Earnings (Forward) | 9.98 |
| Price / Sales | 0.760 |
| Price / Book | 0.780 |
| 52 Weeks Range | |
| Earnings Date | 29 Jul 2025 - 4 Aug 2025 |
| Profit Margin | 8.10% |
| Operating Margin (TTM) | 13.36% |
| Diluted EPS (TTM) | 2.78 |
| Quarterly Revenue Growth (YOY) | 4.20% |
| Quarterly Earnings Growth (YOY) | -43.50% |
| Total Debt/Equity (MRQ) | 65.69% |
| Current Ratio (MRQ) | 1.00 |
| Operating Cash Flow (TTM) | 129.69 M |
| Levered Free Cash Flow (TTM) | -605.91 M |
| Return on Assets (TTM) | 5.77% |
| Return on Equity (TTM) | 8.70% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Acadia Healthcare Company, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | 1.5 |
| Price Volatility | 1.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 2.0 |
| Average | 1.70 |
|
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 1.40% |
| % Held by Institutions | 111.18% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| P2 Capital Partners, Llc | 31 Dec 2024 | 2,194,288 |
| Sachem Head Capital Management Lp | 31 Dec 2024 | 1,330,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 55.00 (Keybanc, 120.40%) | Buy |
| Median | 39.50 (58.29%) | |
| Low | 28.00 (Barclays, 12.20%) | Hold |
| Average | 39.75 (59.29%) | |
| Total | 4 Buy, 2 Hold | |
| Avg. Price @ Call | 27.58 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 14 May 2025 | 28.00 (12.20%) | Hold | 25.72 |
| 28 Feb 2025 | 35.00 (40.25%) | Hold | 29.98 | |
| Keybanc | 14 May 2025 | 55.00 (120.40%) | Buy | 25.72 |
| 03 Mar 2025 | 65.00 (160.47%) | Buy | 29.26 | |
| Mizuho | 14 May 2025 | 32.00 (28.23%) | Hold | 25.72 |
| 25 Mar 2025 | 37.00 (48.27%) | Hold | 28.81 | |
| Guggenheim | 09 Apr 2025 | 36.00 (44.26%) | Buy | 29.10 |
| RBC Capital | 03 Mar 2025 | 43.00 (72.31%) | Buy | 29.26 |
| B of A Securities | 28 Feb 2025 | 44.50 (78.32%) | Buy | 29.98 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 May 2025 | Announcement | Acadia Healthcare Reports First Quarter 2025 Results |
| 08 May 2025 | Announcement | Acadia Healthcare to Participate in BofA Securities Health Care Conference |
| 16 Apr 2025 | Announcement | Acadia Healthcare Announces Date for First Quarter 2025 Earnings Release |
| 06 Mar 2025 | Announcement | Acadia Healthcare Announces Pricing of $550 Million Senior Notes Due 2033 |
| 05 Mar 2025 | Announcement | Acadia Healthcare Announces Launch of $500 Million Senior Notes Offering |
| 27 Feb 2025 | Announcement | Acadia Healthcare Reports Fourth Quarter 2024 Results |
| 21 Feb 2025 | Announcement | Acadia Healthcare to Participate in March Investor Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |